Verification evidence is still being completed.
PDF / print export
Medix Biochemica
Espoo, Finland
- Verified lead
- Steve Ferguson
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- IVD Raw Materials, Antibodies, Antigens, and Diagnostic Reagents
- Review cycle
- May 2026
- Full address
- Klovinpellontie 3, FI-02180 Espoo, Finland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Medix Biochemica announcement quoting Steve Ferguson as CEO.
- Editorial note
- Medix Biochemica adds a Finnish diagnostics-manufacturing anchor with attributable executive coverage, Espoo headquarters evidence, and a source-backed industrial IVD narrative.
IVD Raw Materials, Antibodies, Antigens, and Diagnostic Reagents
ISO 13485, FDA QSR-aligned quality system
Medix Biochemica adds a Finnish diagnostics-manufacturing anchor with attributable executive coverage, Espoo headquarters evidence, and a source-backed industrial IVD narrative.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Espoo, Finland
Medix Biochemica
IVD Raw Materials, Antibodies, Antigens, and Diagnostic Reagents · Industrial IVD raw-material manufacturing
Medix Biochemica adds a Finnish diagnostics-manufacturing anchor with attributable executive coverage, Espoo headquarters evidence, and a source-backed industrial IVD narrative.
- Lead
- Steve Ferguson (verified ↗)
- Address
- Klovinpellontie 3, FI-02180 Espoo, Finland (source ↗)
- Compliance
- ISO 13485 · FDA QSR-aligned quality system
- Last reviewed
- 15 Mar 2026 (3mo ago)
- Scale
- Industrial IVD raw-material manufacturing
- Capabilities
- IVD Raw Material Manufacturing · Antibodies and Antigens · Assay Development Support
- Founded
- 1985
- Headcount
- 201-500
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Steve Ferguson
Chief Executive Officer
Full addressKlovinpellontie 3, FI-02180 Espoo, Finland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Industrial IVD raw-material manufacturing
Espoo, Finland. IVD Raw Materials, Antibodies, Antigens, and Diagnostic Reagents. Review completed on 15 Mar 2026.
Finnish medical-device and IVD quality oversight
ISO 13485, FDA QSR-aligned quality system
IVD Raw Materials, Antibodies, Antigens, and Diagnostic Reagents
Medix Biochemica adds a Finnish diagnostics-manufacturing anchor with attributable executive coverage, Espoo headquarters evidence, and a source-backed industrial IVD narrative.
Editorial note
Medix Biochemica adds a Finnish diagnostics-manufacturing anchor with attributable executive coverage, Espoo headquarters evidence, and a source-backed industrial IVD narrative.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
IVD Raw Material Manufacturing
Antibodies and Antigens
Assay Development Support
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Antibody and antigen production suites
Analytical QC laboratories
Molecular diagnostics development platforms
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- VERIFIED ACTIVE 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
15 Mar 2026: Executive identity confirmed via official management disclosure.
15 Mar 2026: Trust review remains in progress.
FAQ
Frequently asked questions
- Where is Medix Biochemica located?
- Medix Biochemica operates from Klovinpellontie 3, FI-02180 Espoo, Finland, Espoo, Finland.
- Who runs Medix Biochemica?
- Medix Biochemica is led by Steve Ferguson, Chief Executive Officer. Verified 15 Mar 2026.
- What certifications does Medix Biochemica hold?
- Medix Biochemica is documented under ISO 13485, FDA QSR-aligned quality system.
- What does Medix Biochemica do?
- Medix Biochemica adds a Finnish diagnostics-manufacturing anchor with attributable executive coverage, Espoo headquarters evidence, and a source-backed industrial IVD narrative. Core capabilities: IVD Raw Material Manufacturing, Antibodies and Antigens, Assay Development Support.
Editorial context
Related technical briefs
Briefs that name Espoo as a covered market or city.